Hydrocephalus beyond cerebrospinal fluid obstruction: systems biology mechanisms and AI-enabled multimodal imaging for precision diagnosis and management
Jul 2026· European Journal of Medical Research· Vol 31· 0 citations· 142 references
TL;DR
A broad perspective underscores hydrocephalus as a systemic disorder rather than a purely hydrodynamic abnormality and argues that future progress will depend on integrating multicentre datasets with multi-omics technologies.
Abstract
Research paradigms in hydrocephalus are undergoing a profound shift—from a singular emphasis on CSF flow disturbance to a multi-mechanistic, network-interaction model. This review systematically integrates cutting-edge advances from fundamental biology to clinical diagnosis and therapy. Mechanistically, we delineate an interconnected pathological network encompassing neuroinflammation (e.g., the TLR4/NF-κB axis), glymphatic system dysfunction, cilia–ependymal dysregulation, and genetic susceptibility. This broad perspective underscores hydrocephalus as a systemic disorder rather than a purely hydrodynamic abnormality. Technologically, we highlight innovations driven by artificial intelligence (AI) and multimodal neuroimaging—including 4D flow MRI, DTI, and radiomics. These tools enable automated ventricular segmentation, quantitative fluid-dynamic profiling, and robust predictions of surgical outcomes. Consequently, they establish the technical foundation for a "data-driven" paradigm in diagnostics and therapeutics. Therapeutically, we discuss the expanding repertoire of interventions, extending beyond conventional shunt surgery to refined microsurgical techniques, targeted pharmacotherapies, and stem cell–based strategies. Finally, we argue that future progress will depend on integrating multicentre datasets with multi-omics technologies. Establishing this coordinated “mechanism–technology–clinic” framework will accelerate hydrocephalus management toward truly personalized precision medicine.
Diagnostic testing and neurosurgical management involving CSF shunting in patients with idiopathic normal pressure hydrocephalus (iNPH) offers a unique, ethically sustainable opportunity to study the aging human brain. The common co-occurrence of neurodegenerative pathologies such as amyloid-β plaques and neurofibril...
Heikki E. M. Lukkarinen, A. Luikku, Antonios Dougalis et al.· Alzheimer's Research & T...· 0 citations
Temporal lobe epilepsy (TLE) is increasingly conceptualized not as an isolated hippocampal lesion, but as a complex, multiscale limbic network connectomic disorder. Despite advances in pharmacological management, over 30% of patients experience drug-resistant epilepsy, underscoring the urgent need to shift from symptom...
Károly Orbán-Kis, K. Kelemen, Rita-Judit Kiss et al.· International Journal of Mol...· 0 citations
Severe traumatic brain injury (TBI) remains difficult to treat because successful control of mass lesions, intracranial pressure, cerebral perfusion, oxygenation, and systemic instability does not ensure that secondary cellular injury has stopped. PubMed/MEDLINE and ClinicalTrials.gov were searched through July 28, 202...
J. Choi, K. Jo· Journal of Korean Neurosurgi...· 0 citations
While these multimodal biomarkers offer unprecedented mechanistic insights into disease progression and therapeutic response, their ultimate value depends on successful clinical translation, it would be essential for the field to prioritize standardized acquisition protocols, automated post-processing pipelines, and ac...
E. Haacke, S. Buch, Naying He et al.· NeuroImage· 0 citations
The neuropathological and imaging evidence linking cortical pathology to meningeal inflammation, neuroaxonal injury and progression independent of relapse activity is examined, and how emerging magnetic resonance imaging approaches for detecting and monitoring cortical lesions contribute to diagnosis and prognosis acro...
Massimiliano Calabrese, Roberta Magliozzi, Agnese Tamanti et al.· Nature Reviews Neurology· 0 citations
Traumatic brain injury (TBI) is characterized by a "translational paradox", where robust preclinical successes rarely achieve clinical efficacy. This review provides a critical appraisal of emerging therapeutics, moving beyond traditional silos to propose a unified, stage-dependent roadmap for neurorestoration. Reflect...
Ana Costa, Steven Davidson, Emiliya Rakhamimova et al.· Frontiers in Bioscience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.